Jaumot Frank E 4

What Happened

• Frank E. Jaumot, a director of Nutex Health, reported a purchase of 150 shares (transaction code P) on 2026-03-20. The shares were acquired at $93.56 per share for a total reported cost of $14,033. The filing describes the transaction as an open-market or private purchase (code P).

Key Details

• Transaction date and price: March 20, 2026 — 150 shares at $93.56/share.
• Total value: $14,033.
• Filing date: March 23, 2026 — filed with the SEC within the normal two-business-day Form 4 window (timely).
• Shares owned after transaction: Not specified in the reported filing.
• Footnotes/notable items: The filing does not indicate a 10b5-1 plan, tax withholding, or other special conditions.

Context

• This was a purchase (code P). Insider purchases can be interpreted by investors as a greater signal of personal conviction than routine sales, but they are not proof of future company performance.
• At $14k, this is a modest-sized insider buy relative to many institutional trades; treat it as one data point among other insider activity and company fundamentals.